Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to kidney or heart transplantation or when they are affected by concomitant HIV infection. This recrudescence, however, does not occur in all chagasic patients exposed to immunosuppressive agents. We therefore investigated the influence of Trypanosoma cruzi strains in the recrudescence of the parasitism in mice at the chronic phase treated with cyclophosphamide, an immunosuppressor that blocks lymphocytes DNA synthesis and therefore controls B cells response. A large variation was detected in the percentages of newly established acute phases in the groups of mice inoculated with the different strains. We suggest that reactivation of ch...
Re-infections with Trypanosoma cruzi are an aggravating factor for Chagas disease morbidity. The Col...
Chagas disease courses with different clinical phases and has a variable clinical presentation and p...
Reinfection of chronic chagasic mice after treatment with nifurtimox resulted in different outcomes ...
Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to ...
Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to k...
Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to k...
The factors involved in the reactivation of chronic Chagas disease infection are not clear enough an...
Latent Trypanosoma cruzi infection may be reactivated in immunosuppressed individuals, with unusual ...
Acute infection with Trypanosoma cruzi results in intense myocarditis, which progresses to a chronic...
Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldw...
In this article, we have characterized cell subpopulations found in the hearts of mice presenting ac...
Re-infections with Trypanosoma cruzi are an aggravating factor for Chagas disease morbidity. The Col...
Strains of Trypanosoma cruzi are multiclonal populations that can be classified in groups or genotyp...
The in vivo effects of cyclosporin A (CsA) on Trypanosoma cruzi infection were examined using differ...
To investigate functional changes in Trypanosoma cruzi parasites induced during their interaction wi...
Re-infections with Trypanosoma cruzi are an aggravating factor for Chagas disease morbidity. The Col...
Chagas disease courses with different clinical phases and has a variable clinical presentation and p...
Reinfection of chronic chagasic mice after treatment with nifurtimox resulted in different outcomes ...
Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to ...
Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to k...
Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to k...
The factors involved in the reactivation of chronic Chagas disease infection are not clear enough an...
Latent Trypanosoma cruzi infection may be reactivated in immunosuppressed individuals, with unusual ...
Acute infection with Trypanosoma cruzi results in intense myocarditis, which progresses to a chronic...
Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldw...
In this article, we have characterized cell subpopulations found in the hearts of mice presenting ac...
Re-infections with Trypanosoma cruzi are an aggravating factor for Chagas disease morbidity. The Col...
Strains of Trypanosoma cruzi are multiclonal populations that can be classified in groups or genotyp...
The in vivo effects of cyclosporin A (CsA) on Trypanosoma cruzi infection were examined using differ...
To investigate functional changes in Trypanosoma cruzi parasites induced during their interaction wi...
Re-infections with Trypanosoma cruzi are an aggravating factor for Chagas disease morbidity. The Col...
Chagas disease courses with different clinical phases and has a variable clinical presentation and p...
Reinfection of chronic chagasic mice after treatment with nifurtimox resulted in different outcomes ...